Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later

被引:101
|
作者
Eggimann, Philippe [1 ]
Pittet, Didier [2 ,3 ]
机构
[1] CHU Vaudois, Adult Crit Care Med & Burn Unit, Lausanne, Switzerland
[2] HUG, Fac Med, Infect Control Program, CH-1205 Geneva, Switzerland
[3] HUG, WHO Collaborating Ctr Patient Safety, CH-1205 Geneva, Switzerland
关键词
Candida albicans; Candidemia; Invasive candidiasis; Colonization; Colonization index; Empirical treatment; Nosocomial infections; INTENSIVE-CARE-UNIT; ORAL NYSTATIN PROPHYLAXIS; PLACEBO-CONTROLLED TRIAL; BLOOD-STREAM INFECTION; INVASIVE CANDIDIASIS; HIGH-RISK; INTRAABDOMINAL CANDIDIASIS; FLUCONAZOLE PROPHYLAXIS; SPP; COLONIZATION; ICU PATIENTS;
D O I
10.1007/s00134-014-3355-z
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
For decades, clinicians dealing with immunocompromised and critically ill patients have perceived a link between Candida colonization and subsequent infection. However, the pathophysiological progression from colonization to infection was clearly established only through the formal description of the colonization index (CI) in critically ill patients. Unfortunately, the literature reflects intense confusion about the pathophysiology of invasive candidiasis and specific associated risk factors. We review the contribution of the CI in the field of Candida infection and its development in the 20 years following its original description in 1994. The development of the CI enabled an improved understanding of the pathogenesis of invasive candidiasis and the use of targeted empirical antifungal therapy in subgroups of patients at increased risk for infection. The recognition of specific characteristics among underlying conditions, such as neutropenia, solid organ transplantation, and surgical and nonsurgical critical illness, has enabled the description of distinct epidemiological patterns in the development of invasive candidiasis. Despite its limited bedside practicality and before confirmation of potentially more accurate predictors, such as specific biomarkers, the CI remains an important way to characterize the dynamics of colonization, which increases early in patients who develop invasive candidiasis.
引用
收藏
页码:1429 / 1448
页数:20
相关论文
共 50 条
  • [21] Host Factors and Clinical Outcomes of Candida Colonization in Critically Ill Patients
    Jacobs, David M.
    Beyda, Nicholas D.
    Asuphon, Orarik
    Alam, M. Jahangir
    Garey, Kevin W.
    MYCOPATHOLOGIA, 2015, 179 (1-2) : 87 - 93
  • [22] Clostridioides difficile colonization and the frequency of subsequent treatment for C. difficile infection in critically ill patients
    MacKenzie, Erica L.
    Murillo, Cynthia
    Bartlett, Allison H.
    Marrs, Rachel
    Landon, Emily M.
    Ridgway, Jessica P.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (11) : 1782 - 1787
  • [23] Multifocal Candida species colonization as a trigger for early antifungal therapy in critically ill patients:: What about other risk factors for fungal infection?
    Charles, PE
    CRITICAL CARE MEDICINE, 2006, 34 (03) : 913 - 914
  • [24] Host Factors and Clinical Outcomes of Candida Colonization in Critically Ill Patients
    David M. Jacobs
    Nicholas D. Beyda
    Orarik Asuphon
    M. Jahangir Alam
    Kevin W. Garey
    Mycopathologia, 2015, 179 : 87 - 93
  • [25] Systemic antifungal therapy in critically ill patients without invasive fungal infection
    Azoulay, Elie
    Dupont, Herve
    Tabah, Alexis
    Lortholary, Olivier
    Stahl, Jean-Paul
    Francais, Adrien
    Martin, Claude
    Guidet, Bertand
    Timsit, Jean-Francois
    CRITICAL CARE MEDICINE, 2012, 40 (03) : 813 - 822
  • [26] Colonization by Candida auris in critically ill patients: role of cutaneous and rectal localization during an outbreak
    Piatti, G.
    Sartini, M.
    Cusato, C.
    Schito, A. M.
    JOURNAL OF HOSPITAL INFECTION, 2022, 120 : 85 - 89
  • [27] Risk Factors for Invasive Candida Infection in Critically Ill Patients A Systematic Review and Meta-analysis
    Thomas-Ruddel, Daniel O.
    Schlattmann, Peter
    Pletz, Mathias
    Kurzai, Oliver
    Bloos, Frank
    CHEST, 2022, 161 (02) : 345 - 355
  • [28] A clinical predictive model of candidaemia by Candida auris in previously colonized critically ill patients
    Garcia-Bustos, V.
    Salavert, M.
    Ruiz-Gaitan, A. C.
    Cabanero-Navalon, M. D.
    Sigona-Giangreco, I. A.
    Peman, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (11) : 1507 - 1513
  • [29] A scoring model of factors associated with Candida glabrata candidemia among critically ill patients
    Tapia, Gino G.
    Razonable, Raymund R.
    Eckel-Passow, Jeanette E.
    Lahr, Brian D.
    Afessa, Bekele
    Keegan, Mark T.
    Catania, Jelena
    Baddour, Larry M.
    MYCOSES, 2012, 55 (03) : 228 - 236
  • [30] Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
    Bruyere, Remi
    Quenot, Jean-Pierre
    Prin, Sebastien
    Dalle, Frederic
    Vigneron, Clara
    Aho, Serge
    Leon, Cristobal
    Charles, Pierre-Emmanuel
    BMC INFECTIOUS DISEASES, 2014, 14